Int J Biol Sci 2020; 16(13):2379-2381. doi:10.7150/ijbs.49433

Erratum

Andrographolide Suppress Tumor Growth by Inhibiting TLR4/NF-κB Signaling Activation in Insulinoma: Erratum

Qian-Qian Zhang1*, Yi Ding1*, Yan Lei1, Cui-Ling Qi1, Xiao-Dong He1, Tian Lan1, Jiang-Chao Li1, Ping Gong1, Xuesong Yang3, Jian-Guo Geng2✉, Li-Jing Wang1✉

1. Vascular Biology Research Institute, Guangdong Key Laboratory of Pharmaceutical Bioactive Substances, Guangdong Pharmaceutical University, Guangzhou 510006, China.
2. Department of Biologic and Materials Sciences, University of Michigan School of Dentistry, Ann Arbor, MI 48109, USA.
3. Department of Histology and Embryology, Key Laboratory for Regenerative Medicine of the Ministry of Education, Medical College of Jinan University, Guangzhou 510632, China.
* These authors contributed equally to this work.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Citation:
Zhang QQ, Ding Y, Lei Y, Qi CL, He XD, Lan T, Li JC, Gong P, Yang X, Geng JG, Wang LJ. Andrographolide Suppress Tumor Growth by Inhibiting TLR4/NF-κB Signaling Activation in Insulinoma: Erratum. Int J Biol Sci 2020; 16(13):2379-2381. doi:10.7150/ijbs.49433. Available from http://www.ijbs.com/v16p2379.htm

File import instruction

Corrected-article in Int J Biol Sci, Volume 10, 404